Outcomes in Real-life after Initation of treatment with Trixeo (Budesonide / Glycopyrronium / Formoterol)

Trial Identifier: D5980R00076
Sponsor: AstraZeneca
Start Date: June 2023
Primary Completion Date: May 2025
Study Completion Date: May 2025
Condition: Chronic Obstructive Pulmonary Disease (COPD)

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Italy Acquaviva delle Fonti, Italy
Italy Alessandria, Italy
Italy Ancona, Italy
Italy Avellino, Italy
Italy Brescia, Italy
Italy Brindisi, Italy
Italy Busto Arsizio (Varese), Italy
Italy Catania, Italy
Italy Catanzaro, Italy
Italy Cittadella (Padova), Italy
Italy Firenze, Italy
Italy Foggia, Italy
Italy Lecce, Italy
Italy Napoli, Italy
Italy Passirana (Milano), Italy
Italy Pavia, Italy
Italy Roma, Italy
Italy Torino, Italy
Italy Treviso, Italy
Italy Verona, Italy